Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
Abstract In patients with atherosclerotic cardiovascular disease (ASCVD) under statin treatment, the influence of on-treatment level of high-density lipoprotein cholesterol (HDL-C) on cardiovascular (CV) events is controversial. Statin-treated patients were selected from the Taiwanese Secondary Prev...
Guardado en:
Autores principales: | Yi-Heng Li, Wei-Kung Tseng, Wei-Hsian Yin, Fang-Ju Lin, Yen-Wen Wu, I-Chang Hsieh, Tsung-Hsien Lin, Wayne Huey-Herng Sheu, Hung-I Yeh, Jaw-Wen Chen, Chau-Chung Wu, Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a168825f796141f7b2334fc19a9e291a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Residual Risk Factors to Predict Major Adverse Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with and without Diabetes Mellitus
por: Fang-Ju Lin, et al.
Publicado: (2017) -
Fenofibrate attenuates doxorubicin-induced cardiac dysfunction in mice via activating the eNOS/EPC pathway
por: Wen-Pin Huang, et al.
Publicado: (2021) -
The association of atherosclerotic cardiovascular disease and statin use with inflammation and treatment outcomes in tuberculosis
por: Vignesh Chidambaram, et al.
Publicado: (2021) -
Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks
por: Yu-Cheng Kao, et al.
Publicado: (2021) -
Synergistic effect of renalase and chronic kidney disease on endothelin-1 in patients with coronary artery disease ‒ a cross-sectional study
por: Yu-Hsuan Li, et al.
Publicado: (2018)